High-risk patients should be prescribed glucagon emergency kits and receive training in their use, with similar training provided to household members
Is very confident in their ability to win the cases they choose to handle
Smieszek et al., 2018)
Preserving those beta cells, keeping them healthy and alive and, eventually, increasing their number and function through disease-modifying therapies is one of Breakthrough T1Ds key priority areas
During this session, well review your health history, discuss any specific symptoms or objectives you have, and recommend the best IV therapy options tailored to your needs
Its crucial to investigate whether GLP-1 receptor agonists and SGLT-2 inhibitors could serve as disease-modifying therapies for Alzheimers disease in humans by targeting the diseases biology directly, beyond these drugs known antidiabetic effects, Dr